TIBET AIM PHARM INTIBET AIM PHARM INTIBET AIM PHARM IN

TIBET AIM PHARM IN

No trades
See on Supercharts
Market capitalization
‪2.42 B‬CNY
0.18CNY
‪15.39 M‬CNY
‪655.52 M‬CNY
‪157.40 M‬
Beta (1Y)
1.35
Employees (FY)
439
Change (1Y)
−8 −1.79%
Revenue / Employee (1Y)
‪1.49 M‬CNY
Net income / Employee (1Y)
‪35.05 K‬CNY

About TIBET AIM PHARM IN


CEO
Min Zhou
Headquarters
Chengdu
Website
Founded
2007
ISIN
CNE100002C39
FIGI
BBG00C9R5XT5
Tibet Aim Pharm., Inc. engages in the research and development, production, and sale of chemical drugs, and Chinese medicines. Its products include miglitol tablets, gualoupi injections, nalmefene hydrochloride injections, carbetocin injections, hongjin xiaojie tablets, and aceclofenac enteric-coated tablets. The company was founded on December 29, 2007 and is headquartered in Chengdu, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 002826 is 12.24 CNY — it has decreased by −5.15% in the past 24 hours. Watch TIBET AIM PHARM IN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange TIBET AIM PHARM IN stocks are traded under the ticker 002826.
002826 stock has fallen by −5.08% compared to the previous week, the month change is a 9.86% rise, over the last year TIBET AIM PHARM IN has showed a 1.83% increase.
002826 reached its all-time high on Feb 28, 2017 with the price of 35.60 CNY, and its all-time low was 5.57 CNY and was reached on Feb 8, 2024. View more price dynamics on 002826 chart.
See other stocks reaching their highest and lowest prices.
002826 stock is 5.17% volatile and has beta coefficient of 1.35. Track TIBET AIM PHARM IN stock price on the chart and check out the list of the most volatile stocks — is TIBET AIM PHARM IN there?
Today TIBET AIM PHARM IN has the market capitalization of ‪2.23 B‬, it has increased by 0.16% over the last week.
Yes, you can track TIBET AIM PHARM IN financials in yearly and quarterly reports right on TradingView.
002826 net income for the last quarter is ‪2.17 M‬ CNY, while the quarter before that showed ‪11.75 M‬ CNY of net income which accounts for −81.50% change. Track more TIBET AIM PHARM IN financial stats to get the full picture.
Yes, 002826 dividends are paid annually. The last dividend per share was 0.03 CNY. As of today, Dividend Yield (TTM)% is 0.25%. Tracking TIBET AIM PHARM IN dividends might help you take more informed decisions.
TIBET AIM PHARM IN dividend yield was 0.25% in 2023, and payout ratio reached 37.17%. The year before the numbers were 0.98% and 43.20% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 18, 2024, the company has 439.00 employees. See our rating of the largest employees — is TIBET AIM PHARM IN on this list?
Like other stocks, 002826 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TIBET AIM PHARM IN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TIBET AIM PHARM IN technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TIBET AIM PHARM IN stock shows the strong buy signal. See more of TIBET AIM PHARM IN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.